References

  1. Bonnet F, Morlat P, Chêne G, Mercié P, Neau D, Chossat I, et al. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med. 2002;3(3):195-9. PubMed | Google Scholar

  2. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 1999. 2006 Sep;43(1):27-34. PubMed | Google Scholar

  3. Etard J-F, Ndiaye I, Thierry-Mieg M, Guèye NFN, Guèye PM, Lanièce I, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS Lond Engl. 2006 May 12;20(8):1181-9. PubMed | Google Scholar

  4. Monforte A d'Arminio, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I CO N A, Study Group; AIDS. 2000 Mar;14(5):499-507. PubMed | Google Scholar

  5. Cesar C, Shepherd BE, Krolewiecki AJ, Fink VI, Schechter M, Tuboi SH, et al. Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America, Myer L, editor. PLoS ONE. 2010 Jun 1;5(6):e10490. PubMed | Google Scholar

  6. Mocroft A, Youle M, Moore A, Sabin CA, Madge S, Lepri AC, et al. Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS. 2001 Jan;15(2):185-94. PubMed | Google Scholar

  7. Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, et al. Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr 1999. 2006 Jan 1;41(1):53-8. PubMed | Google Scholar

  8. Tayal V, Gupta U, Nagpal M, Kumar S. Adverse drug reactions to antiretroviral therapy in aids patients at a tertiary care hospital in India: A prospective observational study. Indian J Med Sci. 2010;64(6):245. PubMed | Google Scholar

  9. Namme Luma H, Doualla M-S, Choukem S-P, Temfack E, et al. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study. Pan Afr Med J. 2012;12:87. PubMed | Google Scholar

  10. Curkendall SM, Richardson JT, Emons MF, Fisher AE, Everhard F. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy. HIV Med. 2007 Nov;8(8):483-90. PubMed | Google Scholar

  11. WHO. The 3 by 5 Initiative. WHO. Available from: http://www.who.int/3by5/en/. Accessed on 29/08/2013.

  12. WHO. Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach.
    Available from: http://www.who.int/3by5/publications/documents/arv_guidelines/en/. Accessed on 29/08/2013.

  13. Teodor A, Teodor D, Luca V. Side effects of antiretroviral therapy. Rev Med Chir Soc Med Nat Iasi. 2004 Mar;108(1):23-6. PubMed | Google Scholar

  14. Subbaraman R, Chaguturu SK, Mayer KH, Flanigan TP, Kumarasamy N. Adverse Effects of Highly Active Antiretroviral Therapy in Developing Countries. Clin Infect Dis. 2007 Oct 15;45(8):1093-101. PubMed | Google Scholar

  15. Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenal B, Lai AR, Saghayam S, et al. Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDs. 2008 Apr;22(4):337-44. PubMed | Google Scholar

  16. Wabe N, Woldemedhin B. The reason for regimen change among HIV/AIDS patients initiated on first line highly active antiretroviral therapy in Southern Ethiopia. North Am J Med Sci. 2012;4(1):19. PubMed | Google Scholar

  17. Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, Fraune M, et al. Detection of Highly Prevalent Hepatitis B Virus Coinfection among HIV-Seropositive Persons in Ghana. J Clin Microbiol. 2010 Sep 1;48(9):3223-30. PubMed | Google Scholar

  18. Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenol B, Saghayam S, Yepthomi T, et al. Gender-based differences in treatment and outcome among HIV patients in South India. J Womens Heal 2002. 2008 Nov;17(9):1471-5. PubMed | Google Scholar

  19. Currier JS, Spino C, Grimes J, Wofsy CB, Katzenstein DA, Hughes MD, et al. Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. J Acquir Immune Defic Syndr. 2000;24(4):316-24. PubMed | Google Scholar